OpGen, Inc. (NASDAQ:OPGN – Get Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.02 and traded as high as $1.25. OpGen shares last traded at $1.25, with a volume of 962 shares.
Analysts Set New Price Targets
Separately, StockNews.com started coverage on OpGen in a research note on Friday. They set a “sell” rating on the stock.
View Our Latest Research Report on OPGN
OpGen Trading Up 1.6 %
OpGen Company Profile
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
See Also
- Five stocks we like better than OpGen
- 5 discounted opportunities for dividend growth investors
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What is a Secondary Public Offering? What Investors Need to Know
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- The How And Why of Investing in Oil Stocks
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
